DNAe Launches Early Access Program for NGS Diagnostic Platform
Hospital teams can trial the company’s BSI/AMR test and preview the LiDia-SEQ system ahead of commercial launch.
Read MorePosted by CLP Edit Staff | Dec 12, 2025 | Molecular Diagnostics |
Hospital teams can trial the company’s BSI/AMR test and preview the LiDia-SEQ system ahead of commercial launch.
Read MorePosted by CLP Edit Staff | Dec 11, 2025 | Sepsis |
The eight-minute test also shortened hospital stays by nearly two days at Froedtert Hospital, reinforcing previous multi-site evidence.
Read MorePosted by CLP Edit Staff | Dec 10, 2025 | Infectious Diseases |
The rapid PCR test delivers results up to 75% faster than other point-of-care HCV diagnostics, enabling same-day treatment initiation.
Read MorePosted by CLP Edit Staff | Dec 9, 2025 | Cancer |
Research analyzing cell-free DNA fragmentation patterns in healthy individuals reveals physiological confounders that could improve test accuracy.
Read MorePosted by CLP Edit Staff | Dec 8, 2025 | Molecular Diagnostics |
The precision medicine company now has 57 approvals in the US and 43 in Japan for its FoundationOne CDx and FoundationOne Liquid CDx tests.
Read More